home / stock / gth / gth news

GTH News and Press, Genetron Holdings Limited From 10/12/22

Stock Information
Company Name: Genetron Holdings Limited
Stock Symbol: GTH
Market: NASDAQ
Website: genetronhealth.com
Menu
GTH GTH Quote GTH Short GTH News GTH Articles GTH Message Board
Get GTH Alerts

News, Short Squeeze, Breakout and More Instantly...
GTH - Genetron Health Reports Unaudited Second Quarter 2022 Financial Results

BEIJING, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics de...
GTH - Genetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

BEIJING, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“ Genetron Health ” or the “ Company ”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screen...

GTH - China's Genetron gets acquisition offer from co-founder/CEO

Genetron ( NASDAQ: GTH ) said it received a preliminary non-binding proposal from its Co-founder, Chairman and CEO Sizhen Wang to acquire the company for US$0.272 per ordinary share or US$1.36 per ADS in cash. Wang intends to fund the proposed transaction via a co...

GTH - Genetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

BEIJING, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“ Genetron Health ” or the “ Company ”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni...
GTH - Genetron Health to Present at the SVB Leerink CybeRx Series: Liquid Biopsy & Oncology Dx Summit

BEIJING, April 01, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products...

GTH - Genetron Health Presented Its Proprietary Early Screening Technology Mutation Capsule at Science/AAAS Webinar

Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH) sponsored a Science /AAAS Webinar, “Early cancer screening today and tomorrow: Exploring liquid biopsy profiling for diagnosis and treatment”, which launched tod...

GTH - Genetron Holdings EPS beats by $0.05, beats on revenue; outlook

Genetron Holdings (GTH): Q4 Non-GAAP EPS of -$0.02 beats by $0.05; GAAP EPS of -$0.02 beats by $0.04.Revenue of $20.5M beats by $0.36M.FY2021: Revenue to be around RMB615M-RMB625M, representing around 45%-47% growth over 2020.Press Release For further details see: Genetron Holdings EPS ...
GTH - Genetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue Guidance

Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, t...

GTH - Genetron Health Releases New Data Results of HCCscreen(TM) for Liver Cancer Early Screening in China

HCCscreen TM achieved 88% sensitivity and 93% specificity, compared with 71% and 95%, respectively, by ultrasound plus AFP. In early-stage patients, the sensitivities of HCCscreen TM are 85% (tumor size of <3cm) and 96% (3-5 cm). The Company plans to initiat...

GTH - Genetron Health to Participate at Credit Suisse Asian Investment Conference on Mar. 26th, 2021

Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, ...
Previous 10 Next 10